Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Gibbs

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Thrombosis and Thrombolysis|November 6, 2023
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg E Fluharty, et al.
The American Journal of Medicine|February 19, 2021
Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF ScreeningHarry Gibbs, Ben Freedman, Mårten Rosenqvist, et al.
Open Heart|January 20, 2025
Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registryJelle C L Himmelreich, Saverio Virdone, A John Camm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 21, 2019
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular eventsDan Atar, Eivind Berge, Jean-Yves Le Heuzey, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2021
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTEOmri Cohen, Walter Ageno, Alfredo E Farjat, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2021
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTEJeffrey I Weitz, Alfredo E Farjat, Walter Ageno, et al.
Open Heart|July 2, 2024
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AFJelle C L Himmelreich, Saverio Virdone, John Camm, et al.
European Journal of Internal Medicine|August 26, 2025
Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registryPaolo Prandoni, Meg Fluharty, Sebastian Schellong, et al.
The Lancet. Haematology|July 2, 2022
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trialFrank Cools, Saverio Virdone, Jitendra Sawhney, et al.
Thrombosis Research|December 24, 2022
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTEAlexander G G Turpie, Alfredo E Farjat, Sylvia Haas, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Thrombosis and Thrombolysis|November 6, 2023
Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registryPaolo Prandoni, Sylvia Haas, Meg E Fluharty, et al.
The American Journal of Medicine|February 19, 2021
Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF ScreeningHarry Gibbs, Ben Freedman, Mårten Rosenqvist, et al.
Open Heart|January 20, 2025
Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registryJelle C L Himmelreich, Saverio Virdone, A John Camm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 21, 2019
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular eventsDan Atar, Eivind Berge, Jean-Yves Le Heuzey, et al.
Journal of Thrombosis and Haemostasis : JTH|October 29, 2021
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTEOmri Cohen, Walter Ageno, Alfredo E Farjat, et al.
Journal of Thrombosis and Haemostasis : JTH|September 6, 2021
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTEJeffrey I Weitz, Alfredo E Farjat, Walter Ageno, et al.
Open Heart|July 2, 2024
Impact of patient selection in clinical trials: application of ROCKET AF and ARISTOTLE criteria in GARFIELD-AFJelle C L Himmelreich, Saverio Virdone, John Camm, et al.
European Journal of Internal Medicine|August 26, 2025
Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registryPaolo Prandoni, Meg Fluharty, Sebastian Schellong, et al.
The Lancet. Haematology|July 2, 2022
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trialFrank Cools, Saverio Virdone, Jitendra Sawhney, et al.
Thrombosis Research|December 24, 2022
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTEAlexander G G Turpie, Alfredo E Farjat, Sylvia Haas, et al.
Pageof 6